在为巧克力摄入而使用活性炭治疗后,狗患有严重的高血症
Christina Genareo1, Samuel Durkan1
1BluePearl Pet Hospital Pittsburgh, Department of Emergency Medicine & Critical Care, Pittsburgh, Pennsylvania, USA.
概括
在治疗巧克力毒性病的活性炭治疗后,严重的高血症可能会在狗身上发展. 密切监测电解质和神经状态至关重要,特别是在脱水患者或摄入透活性毒素的患者中.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 毒理学 毒理学 毒理学
- 内部医学 内部医学
背景情况:
- 巧克力摄入是狗中毒症的常见原因之一,原因是.
- 活性炭经常用于控制毒素吸收,但存在潜在的并发症.
研究的目的:
- 报告在为巧克力毒性症使用活性炭治疗后,狗患有严重的高血症.
- 为了突出与活性炭相关的风险,在透活性毒素摄入的情况下.
主要方法:
- 一只7岁的Corgi吞下了巧克力布朗尼饼,出现了心动减速和高温症.
- 诱导吐,马罗皮坦和含有索尔比托的活性炭被给予,随后是没有索尔比托的活性炭.
- 这只狗接受了重症监护,包括液体治疗,抗药和通风.
主要成果:
- 狗患有,发作,神经学症状和亚血症.
- 第二次使用活性炭后,血清度迅速增加到174 mmol/L.
- 这只狗在住院57小时后康复,其余的轻度前庭体征稍后消失.
结论:
- 这一案例突显了在巧克力毒性病的狗中使用活性炭治疗后严重高血的风险,特别是当涉及透活性物质时.
- 在复杂的毒性病例中使用活性炭时,建议经常监测电解质和神经状态.
- 临床医生应考虑在接受活性炭用于毒素摄入的风险患者中出现高血的可能性.
相关概念视频
Prevention of Further Absorption of Poison
1.2K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.2K
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K
Enhanced Elimination of Poison
864
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
864
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
602
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
602
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
588
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
588
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
814
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
814


